Revvity (RVTY) Cash from Discontinued Operations (2009 - 2026)
Revvity's (RVTY) quarterly Cash from Discontinued Operations came in at -$10.7 million in Q2 2026, down 79.35% on a YoY basis from -$51.6 million in Q2 2025, and down 13056.79% quarter-over-quarter from -$81000.0 in Q3 2025.
Analysis
Revvity (RVTY) Cash from Discontinued Operations (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Cash from Discontinued Operations for 16 consecutive years, with -$10.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Discontinued Operations fell 79.35% year-over-year to -$10.7 million; the trailing twelve-month figure through Jul 2026 stood at -$10.7 million (up 34.16% YoY), and the FY2025 full-year result was -$6.0 million, up 83.57% from the prior year.
- Cash from Discontinued Operations eased to -$10.7 million in Q2 2026 per RVTY's latest filing, from -$81000.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at -$81000.0 in Q3 2025 and bottomed at -$91.7 million in Q3 2023.
- Historically, Cash from Discontinued Operations has averaged -$27.5 million across 5 years, with a median of -$10.7 million in 2026.
- The widest YoY moves for Cash from Discontinued Operations: up 99.11% in 2025, down 130.04% in 2025.
- Over 5 years, Cash from Discontinued Operations stood at -$42.9 million in 2022, then soared by 44.08% to -$24.0 million in 2023, then soared by 94.84% to -$1.2 million in 2024, then surged by 93.45% to -$81000.0 in 2025, then sank by 13056.79% to -$10.7 million in 2026.
- According to Business Quant data, Cash from Discontinued Operations over the past three periods registered -$10.7 million, -$81000.0, and -$5.9 million for Q2 2026, Q3 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | - |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 5, 2026 | -10.66 Mn |
| Sep 28, 2025 | -81,000.00 |
| Mar 30, 2025 | -5.94 Mn |
| Dec 29, 2024 | -1.24 Mn |
| Sep 29, 2024 | -9.13 Mn |
| Jun 30, 2024 | -23.71 Mn |
| Mar 31, 2024 | -2.58 Mn |
| Dec 31, 2023 | -23.99 Mn |
| Oct 1, 2023 | -64.24 Mn |
| Jul 2, 2023 | -91.67 Mn |
| Apr 2, 2023 | -8.21 Mn |
| Jan 1, 2023 | -73.37 Mn |
| Apr 3, 2022 | -42.91 Mn |
| Jan 3, 2021 | 187.46 Mn |
| Sep 30, 2018 | -200,000.00 |
| Dec 31, 2017 | 1.10 Mn |
| Oct 1, 2017 | -11.01 Mn |
| Jul 2, 2017 | -6.33 Mn |
| Apr 2, 2017 | 12.53 Mn |
| Jan 1, 2017 | 26.91 Mn |